Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Female Reproductive System Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06803381
What this trial is testing

Somesthesia in Cancer Patients: Variability and Influence on Eating Experience

Who this might be right for
Digestive CancersBreast CancerGynecologic Cancer+4 more
Hospices Civils de Lyon 96
Testing effectiveness (Phase 2)Study completedNCT01935934
What this trial is testing

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more
National Cancer Institute (NCI) 102
Not applicableLooking for participantsNCT06709534
What this trial is testing

An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors

Who this might be right for
Malignant Female Reproductive System Neoplasm
Emory University 40
Not applicableStudy completedNCT04298827
What this trial is testing

Gyn Onc Prehab Study

Who this might be right for
Gynecologic CancerOvarian CancerEndometrial Cancer+4 more
St. Louis University 83
Testing effectiveness (Phase 2)Study completedNCT03180294
What this trial is testing

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Who this might be right for
Breast CarcinomaCervical CarcinomaOvarian Carcinoma+4 more
NRG Oncology 230
Not applicableLooking for participantsNCT06087783
What this trial is testing

PROtein, Leucine and Vitamin D Supplementation In Patients With GYnecologic Cancer Receiving Platinum-based Chemotherapy

Who this might be right for
Gynecologic Cancer
Fondazione IRCCS Policlinico San Matteo di Pavia 50
Not applicableUnknownNCT05086783
What this trial is testing

Video-based Coaching (VBC) in Gynecologic Surgery

Who this might be right for
EducationSurgeryGynecologic Cancer
Mount Sinai Hospital, Canada 30
Early research (Phase 1)UnknownNCT03226470
What this trial is testing

Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions

Who this might be right for
Human Papillomavirus-Related Malignant Neoplasm
Huazhong University of Science and Technology 40
Not applicableLooking for participantsNCT06644846
What this trial is testing

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

Who this might be right for
Cervical CancerGynecologic CancerRecurrent Cancer
Tata Memorial Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT04273061
What this trial is testing

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Who this might be right for
Breast CancerLung CancerGastrointestinal Cancer+6 more
British Columbia Cancer Agency 50
Not applicableStudy completedNCT04772118
What this trial is testing

Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management.

Who this might be right for
Lung CancerBreast CancerGynecologic Cancer
Carevive Systems, Inc. 51
Testing effectiveness (Phase 2)Temporarily pausedNCT04042116
What this trial is testing

Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor

Who this might be right for
Advanced Solid TumorGynecologic Cancer
Clovis Oncology, Inc. 227
Early research (Phase 1)UnknownNCT03308604
What this trial is testing

AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy

Who this might be right for
Gynecologic Cancer
Gustave Roussy, Cancer Campus, Grand Paris 18
Early research (Phase 1)Ended earlyNCT03277482
What this trial is testing

Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer

Who this might be right for
Recurrent Gynecological CancerMetastatic Cervical CancerMetastatic Ovarian Cancer+8 more
Dana-Farber Cancer Institute 16
Early research (Phase 1)Looking for participantsNCT06215950
What this trial is testing

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer

Who this might be right for
Ovarian CancerCervix CancerMetastatic Cancer+2 more
Chongqing Precision Biotech Co., Ltd 36
Not applicableLooking for participantsNCT04530890
What this trial is testing

Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer

Who this might be right for
Breast CancerDigestive CancerGynecologic Cancer+2 more
Poitiers University Hospital 1,000
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Large-scale testing (Phase 3)UnknownNCT04999176
What this trial is testing

Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin

Who this might be right for
CancerRivaroxabanVenous Thromboembolism+1 more
André Luiz Malavasi Longo de Oliveira 440
Not applicableEnded earlyNCT03796403
What this trial is testing

Bupivacaine Plus Diclofenac Versus Bupivacaine Alone for Postoperative Pain Relief in Gynecologic Cancer Patients

Who this might be right for
Post-operative Pain
Department of Medical Services Ministry of Public Health of Thailand 140
Testing effectiveness (Phase 2)Ended earlyNCT03610490
What this trial is testing

Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma

Who this might be right for
Malignant Solid NeoplasmMetastatic Colorectal AdenocarcinomaMetastatic Ovarian Carcinoma+9 more
M.D. Anderson Cancer Center 16
Next Page